The store will not work correctly when cookies are disabled.
6-Phenylsulfanyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide
ID: ALA541633
PubChem CID: 12668036
Max Phase: Preclinical
Molecular Formula: C16H18BrNO2S
Molecular Weight: 287.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Br.Oc1cc2c(c(Sc3ccccc3)c1O)CCNCC2
Standard InChI: InChI=1S/C16H17NO2S.BrH/c18-14-10-11-6-8-17-9-7-13(11)16(15(14)19)20-12-4-2-1-3-5-12;/h1-5,10,17-19H,6-9H2;1H
Standard InChI Key: BICCPBUSCXJJOF-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
5.4404 -2.1051 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-1.4884 -1.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8315 -0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8315 0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5580 -3.0236 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.4884 1.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9404 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8685 -1.3662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8911 -3.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8685 1.3662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7442 -1.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7805 1.6880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2325 -1.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2507 1.3976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9632 -5.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1528 -2.9016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4863 -3.5884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2967 -5.8981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5583 -5.0867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
3 5 2 0
4 6 1 0
2 7 1 0
5 8 1 0
6 8 2 0
3 10 1 0
7 11 1 0
5 12 1 0
4 13 1 0
6 14 1 0
9 15 1 0
13 15 1 0
9 16 1 0
14 16 1 0
11 17 1 0
11 18 2 0
18 19 1 0
17 20 2 0
19 21 2 0
20 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 287.38 | Molecular Weight (Monoisotopic): 287.0980 | AlogP: 2.94 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.49 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.91 | CX Basic pKa: 10.10 | CX LogP: 2.42 | CX LogD: 1.21 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.74 | Np Likeness Score: 0.19 |
References
1. Kaiser C, Ali FE, Bondinell WE, Brenner M, Holden KG, Ku TW, Oh HJ, Ross ST, Yim NC, Zirkle CL, Hahn RA, Sarau HM, Setler PE, Wardell JR.. (1980) 6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics., 23 (9): [PMID:6106062] [10.1021/jm00183a002] |